In his weekly clinical update, Dr. Griffin delves into discussing drinking "raw" milk possessing H5N1 influenza virus, if the virus can reproduce in the human gut, and the meaning of finding viral RNA in wastewater samples before reviewing the recent statistics on SARS-CoV-2 infection, the guidelines for spring administration of COVID vaccines boosters, withdrawal of AstraZeneca's SARS-CoV-2 vaccine from the European market, discusses the emergency use application of a pre-exposure prophylactic, continues to dispel the myth of viral rebound, when to use steroids and the benefits of convalescent plasma, what do when healthcare workers succumb to SARS-CoV-2 infection, if administration of colchicine for the management of COVID-19, compares and provides information for the enrollment into the NIH clinical trials of long COVID and its effects on sleep, exercise intolerance and the cognitive profile in multiple sclerosis and post-COVID, exercise intolerance and post-exertional malaise. For more information about cow and milk infection by H5N1 listen to the discussion with Richard Webby on TWiV 1113 and for long COVID-19 listen to TWiV 1088. Dr. Griffin also provides a list of apps for monitoring one's health including brain health.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Who demands milk infected with H5N1? (Futurism)
• Uncowed by milk possessing H5N1 (LA Times)
• Cow flu flying around for 4 months (CNN)
• The unpasteurized raw milk institute (Raw Milk Institute)
• Infection and reproduction of H5N1 in the human gut (JID)
• Wastewater samples identified H5N1 in 9 cities (medrxiv)
• Richard Webby, is H5N1 a concern? (TWiV 1113)
• COVID-19 national trend (CDC)
• COVID-19 deaths (CDC)
• Spring vaccineadvice (CIDRAP)
• Older adult spring booster available (CDC)
• Advisory committee for immunization practices slides (CDC)
• Advisory committee for immunization practices spring 2024 COVID-19 boosters (CDC)
• Withdrawal of Astra-Zeneca SARS-CoV-2 vaccine in Europe (European Medicines Agency)
• Astra-Zeneca withdraws SARS-CoV-2 vaccine from market (AP news)
• Global vaccine data/adverse event network (Vaccine)
• EUA for pemgarda (FDA)
• CDC Quarantine guidelines (CDC)
• Early phase of SARs-CoV-2 infection (COVID.gov)
• NIH COVID-19 treatment guidelines (NIH)
• Infectious Disease Society guidelines for treatment and management (IDSociety)
• Overuse ofantibiotics for COVID-19: a viral disease (European Society of Clinical Microbiology and Infectious Diseases)
• Molnupiravir safety and efficacy (JMV)
• Convalescent plasma recommendation for immunocompromised (IDSociety)
• Outpatient treatment with concomitant vaccine-boosted convalescent plasma (mBio)
• Updated respiratory virus guidances (CDC)
• What do when your heathcare provider is infected with SARS-CoV-2 (CDC)
• Managing healthcare staffing shortages (CDC)
• Steroids,dexamethasone at the right time (OFID)
• Anticoagulation guidelines (hematology.org)
• Colchicine for managing COVID-19 (BMC Pulmonary Medicine)
• Colchicine guidelines (ID Society)
• Long COVID evidence based review TWiV shout out (TWiV 1088)
• NIH long COVID sleep disturbance, exercise intolerance and post exertional malaise clinical trials (NIH News)
• COVID-19 Yorkshire rehabilitation scale (BML Open Respiratory Research)
• Visible heart monitor (Makevisible)
• Bearable app (Bearable)
• Tracking your chronic illness using Flaredown (Flaredown)
• Improving your brain health (BrainHQ)Vanderbilt's long COVID resources: podcasts and books (Vanderbilt University)
• Contribute to our Floating Doctors fundraiser
• Letters read on TWiV 1114
• Dr. Griffin's COVID treatment summary (pdf)
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to [email protected]